Mannheimia haemolytica in bovine respiratory disease
Romanian Journal of Veterinary Sciences · 31.03.2026 · 59 (1) · 213-221
DOI: 10.59463/rjvs.2026.1.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Veterinary Sciences, online erschienen am 31.03.2026. Verfasst von Alexandra Mihaela Mihali und 1 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Mannheimia haemolytica is a major bacterial pathogen in bovine respiratory disease (BRD), particularly in feedlot and intensively managed cattle. Although it colonizes the upper respiratory tract as a commensal, stress, viral infections, or co-infections allow it to invade the lungs, causing severe fibrinous pneumonia. Among its serotypes, A1 and A6 are most frequently associated with clinical disease, with leukotoxin playing a central role in pathogenesis. This review synthesizes current knowledge on the epidemiology, virulence factors, clinical manifestations, diagnosis, prevention, and treatment of M. haemolytica, highlighting emerging concerns such as antimicrobial resistance (AMR) and variable vaccine efficacy. Special attention is given to the Romanian context, integrating local seroepidemiological data and management practices. The review emphasizes knowledge gaps, diagnostic advances, and strategies to mitigate the economic and health impact of BRD.
Zitieren
APA
Mihali, A. M., & Dumitrescu, E. (2026). Mannheimia haemolytica in bovine respiratory disease. Romanian Journal of Veterinary Sciences, 59(1), 213-221. https://doi.org/10.59463/rjvs.2026.1.24
Vancouver
Mihali AM, Dumitrescu E. Mannheimia haemolytica in bovine respiratory disease. Romanian Journal of Veterinary Sciences. 2026;59(1):213-221. doi:10.59463/rjvs.2026.1.24
BibTeX
@article{Mihali2026,
author = {Mihali, Alexandra Mihaela and Dumitrescu, Eugenia},
title = {Mannheimia haemolytica in bovine respiratory disease},
journal = {Romanian Journal of Veterinary Sciences},
year = {2026},
volume = {59},
number = {1},
pages = {213--221},
doi = {10.59463/rjvs.2026.1.24}
}
EUVIMED